Enrique A. Conterno, SVP&Pres, Lilly Diab & Lilly USA at LILLY ELI & CO (LLY), sold 25,000 shares at $121.00 ($3.0M) on 2019-02-15, disclosed to the SEC on 2019-02-20.
Seasonal sale ($3.0M) by SVP&Pres, Lilly Diab & Lilly USA — this insider has traded LLY in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| FGEN | SELL | 2023-04-11 | $36K | — | Filing → |
| FGEN | SELL | 2023-03-23 | $787K | — | Filing → |
| FGEN | SELL | 2023-03-10 | $1.7M | — | Filing → |